Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.
暂无分享，去创建一个
J. Pignon | T. Conroy | Y. Bécouarn | A. Levy | C. Lemanski | D. Malka | D. Azria | K. Malekzadeh | P. Ezra | E. Rio | I. Martel-Lafay | B. Juzyna | L. Miglianico | A. Delarochefordiere | Julie Leclercq | E. Deutsch | A. Lévy